Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Sep;20(3):281–285. doi: 10.1128/aac.20.3.281

Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.

J L Weeks, E O Mason Jr, C J Baker
PMCID: PMC181688  PMID: 7030197

Abstract

The increasing prevalence of ampicillin-resistant Haemophilus influenzae type b has led to the recommendation that ampicillin and chloramphenicol be given as the initial therapy for suspected bacterial meningitis in infants and children. However, during the first 2 months of life, H. influenzae type b is a rare cause of meningitis, whereas group B streptococcus is the most frequently isolated agent. Since ampicillin and chloramphenicol have been shown to be antagonistic for other streptococci, an in vitro study of their effect on group B streptococci was performed. The effect of ampicillin and chloramphenicol, alone and in combination, on 18 meningeal isolates was determined for 2 different inocula of group B streptococci, using microtiter broth dilution and growth kinetic assays. Isoboles, fractional lethal concentration indices, or both indicated antagonism for all strains. Growth kinetic assays for two representative strains demonstrated inhibition of the early bactericidal activity of ampicillin by chloramphenicol. These findings of in vitro antagonism suggest that this combination may be contraindicated for the treatment of infants with group B streptococcal meningitis.

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper M. D., Keeney R. E., Lyons S. F., Cheatle E. L. Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci. Antimicrob Agents Chemother. 1979 Mar;15(3):484–486. doi: 10.1128/aac.15.3.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Deveikis A., Schauf V., Mizen M., Riff L. Antimicrobial therapy of experimental group B streptococcal infection in mice. Antimicrob Agents Chemother. 1977 May;11(5):817–820. doi: 10.1128/aac.11.5.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ELION G. B., SINGER S., HITCHINGS G. H. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem. 1954 Jun;208(2):477–488. [PubMed] [Google Scholar]
  4. Eickhoff T. C. In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa. Appl Microbiol. 1969 Sep;18(3):469–473. doi: 10.1128/am.18.3.469-473.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Feldman W. E. Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis. J Pediatr. 1976 Apr;88(4 Pt 1):549–552. doi: 10.1016/s0022-3476(76)80003-0. [DOI] [PubMed] [Google Scholar]
  6. JAWETZ E., GUNNISON J. B., SPECK R. S., COLEMAN V. R. Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin. AMA Arch Intern Med. 1951 Mar;87(3):349–359. doi: 10.1001/archinte.1951.03810030022002. [DOI] [PubMed] [Google Scholar]
  7. LEPPER M. H., DOWLING H. F. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin. AMA Arch Intern Med. 1951 Oct;88(4):489–494. doi: 10.1001/archinte.1951.03810100073006. [DOI] [PubMed] [Google Scholar]
  8. MANTEN A., WISSE M. J. Antagonism between antibacterial drugs. Nature. 1961 Nov 18;192:671–672. doi: 10.1038/192671a0. [DOI] [PubMed] [Google Scholar]
  9. Mathies A. W., Jr, Leedom J. M., Ivler D., Wehrle P. F., Portnoy B. Antibiotic antagonism in bacterial meningitis. Antimicrob Agents Chemother (Bethesda) 1967;7:218–224. [PubMed] [Google Scholar]
  10. McCARTY M., LANCEFIELD R. C. Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains. J Exp Med. 1955 Jul 1;102(1):11–28. doi: 10.1084/jem.102.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Overall J. C., Jr Neonatal bacterial meningitis. Analysis of predisposing factors and outcome compared with matched control subjects. J Pediatr. 1970 Apr;76(4):499–511. doi: 10.1016/s0022-3476(70)80399-7. [DOI] [PubMed] [Google Scholar]
  12. Pickering L. K., Hoecker J. L., Kramer W. G., Kohl S., Cleary T. G. Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters. J Pediatr. 1980 Apr;96(4):757–761. doi: 10.1016/s0022-3476(80)80762-1. [DOI] [PubMed] [Google Scholar]
  13. Wallace J. F., Smith R. H., Garcia M., Petersdorf R. G. Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis. J Lab Clin Med. 1967 Sep;70(3):408–418. [PubMed] [Google Scholar]
  14. Wilkinson H. W. Analysis of group B streptococcal types associated with disease in human infants and adults. J Clin Microbiol. 1978 Feb;7(2):176–179. doi: 10.1128/jcm.7.2.176-179.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wilson H. D., Eichenwald H. F. Sepsis neonatorum. Pediatr Clin North Am. 1974 Aug;21(3):571–582. doi: 10.1016/s0031-3955(16)33025-5. [DOI] [PubMed] [Google Scholar]
  16. Yow M. D., Baker C. J., Barrett F. F., Ortigoza C. O. Initial antibiotic management of bacterial meningitis (selection in relationship to age). Medicine (Baltimore) 1973 Jul;52(4):305–309. doi: 10.1097/00005792-197307000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES